WebApr 20, 2024 · London, 20 April 2024 – Hikma Pharmaceuticals PLC (Hikma, Group), the multinational pharmaceutical group, today confirms it has received preliminary approval from the US Federal Trade Commission (FTC) and will now work towards closing its acquisition of Custopharm Inc. from Water Street Healthcare Partners, as previously … WebAmman,Jordan, 12 April 2024 — Hikma Pharmaceuticals PLC (Hikma, Group), announces that Riad Mishlawi, President of the Group’s Injectables business, has been ...
U.S. FTC approves Hikma deal for Custopharm with conditions
WebApr 20, 2024 · Hikma Pharmaceuticals PLC. Follow. WASHINGTON, April 19 (Reuters) - Generic drug maker Hikma Pharmaceuticals (HIK.L) has won U.S. antitrust approval to … WebJul 15, 2024 · Hikma completes acquisition of Custopharm Combination expands US Injectables portfolio and pipeline LONDON, April 21, 2024 /PRNewswire/ -- Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, today announces that it has completed its acquisition of Custopharm Inc. ('Custopharm') from Water … crystal springs dairy company
Hikma Pharmaceuticals/Custopharm (timeline item) - April 18, 2024
WebJun 7, 2024 · Troutman Pepper client Hikma Pharmaceuticals PLC, a multinational pharmaceutical company, ... The combination with Custopharm enhances Hikma’s R&D capabilities and pipeline and expands Hikma’s differentiated U.S. portfolio to nearly 130 commercialized injectable medicines – a more than fivefold increase over the last … WebSep 28, 2024 · Hikma Pharmaceuticals is buying generic sterile injectables company Custopharm as it looks to boost its needle-based treatments business in the US in a deal … WebCustopharm, Inc., Now Hikma Sep 2024 - Present 2 years 8 months. Carlsbad, California, United States Consultant BioPurification, LLC Nov … dynacred llc